Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial
2008
Renal failure in multiple myeloma: Incidence, correlations, and prognostic significance
2007
Maternal Folate and Cobalamin Status Predicts Vitamin Status in Newborns and 6-Month-Old Infants
2010
The relationship between social support and physiological processes: A review with emphasis on underlying mechanisms and implications for health.
1996 Standout
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
CHOP versus MACOP-B in aggressive lymphoma - a Nordic Lymphoma Group randomised trial
1999
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
2014 Standout
Quality of life research within the EORTC—the EORTC QLQ-C30
2002
Paraproteinemic Neuropathies
2001
The Emerging Role of Recombinant-Activated Factor VII in Neurocritical Care
2004
Emerging oral therapies for multiple sclerosis
2007
Rhabdomyolysis and Acute Kidney Injury
2009 Standout
Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial
2003
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
Selective enhancement of the tumour necrotic activity of TNF α with monoclonal antibody
1992
Multiple myeloma
2000 Standout
Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial
2002 Standout
IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines.
1996
The Evidence for the Use of Recombinant Human Activated Factor VII in the Treatment of Bleeding Patients With Quantitative and Qualitative Platelet Disorders
2007
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
2005 Standout
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Natural autoantibodies: from ‘horror autotoxicus’ to ‘gnothi seauton’
1991
Detection of DNA-Recombinant Human Epoetin-Alfa as a Pharmacological Ergogenic Aid
2002
Myeloma Responses and Tolerance Following Combined Kidney and Nonmyeloablative Marrow Transplantation: In Vivo and In Vitro Analyses
2006
Immune Thrombocytopenic Purpura
2002 Standout
Protective and Damaging Effects of Stress Mediators
1998 Standout
Heparin-Induced Thrombocytopenia
2006 Standout
Combinatorial infection andin vivorecombination: a strategy for making large phage antibody repertoires
1993 StandoutNobel
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
2009
Treatment of hairy-cell leukemia
1990
An Antibody Fragment from a Phage Display Library Competes for Ligand Binding to the Low Density Lipoprotein Receptor Family and Inhibits Rhinovirus Infection
1995 StandoutNobel
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Infectious and immunosuppressive complications of purine analog therapy.
1995
Aging and Hypothalamic-Pituitary-Adrenal Response to Challenge in Humans*
1994
Pathogenesis and treatment of renal failure in multiple myeloma
2008
Human Antibody Fragments Specific for Human Blood Group Antigens from a Phage Display Library
1993 StandoutNobel
In vitro selection of RNA aptamers specific for cyanocobalamin
1994 StandoutNobel
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6
1998 StandoutNobel
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Autoimmunity and Apoptosis
2001 StandoutNobel
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
Guiding the Selection of Human Antibodies from Phage Display Repertoires to a Single Epitope of an Antigen
1994 StandoutNobel
Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro
1991
Efficient Removal of Immunoglobulin Free Light Chains by Hemodialysis for Multiple Myeloma
2007
Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA.
1994
Anemia of Chronic Disease
2005 Standout
Phage antibodies against an unstable hapten: Oxygen sensitive reduced flavin
1996 StandoutNobel
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
The role and fate of rabbit and human transcobalamin II in the plasma transport of vitamin B12 in the rabbit.
1976
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
Acute Myeloid Leukemia
2015 Standout
INHIBITION OF GASTRIN AND GASTRIC-ACID SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONE
1974 StandoutNobel
Recombinant Factor VIIa for Bleeding in Refractory Thrombocytopenia
2000
Antibody fragments from a ‘single pot’ phage display library as immunochemical reagents.
1994 StandoutNobel
A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group
2003
Three components of gastrin in human serum Gel filtration studies on the molecular size of immunoreactive serum gastrin
1972
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Multiple Myeloma
2010
Dietary Folic Acid Promotes Survival of Foxp3+ Regulatory T Cells in the Colon
2012 StandoutNobel
Effect of recombinant human erythropoietin combined with granulocyte/ macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome
2000
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Risky families: Family social environments and the mental and physical health of offspring.
2002 Standout
"Diabodies": small bivalent and bispecific antibody fragments.
1993 StandoutNobel
Descriptive and Prognostic Value of Patient-Reported Outcomes: The Bortezomib Experience in Relapsed and Refractory Multiple Myeloma
2006
Growth Factors and Cancer
1991 StandoutScience
Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia
1996
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
Senile dementia of the Alzheimer type
1983
Alzheimer's Disease: Cell-Specific Pathology Isolates the Hippocampal Formation
1984 StandoutScience
Isolation of Vitamin B12-binding Proteins Using Affinity Chromatography
1972
Multiple Myeloma
2011 Standout
Patterns of Survival in Multiple Myeloma: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2003
2007
Implications of Potential Cure in Acute Myelogenous Leukemia: Development of Subsequent Cancer and Return to Work
1997
Human neutrophil activating peptide/interleukin 8 acts as an autoantigen in rheumatoid arthritis.
1992
Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factors
1999
Interleukin-8 as a Macrophage-Derived Mediator of Angiogenesis
1992 StandoutScience
Guam Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Linked to a Plant Excitant Neurotoxin
1987 StandoutScience
Human anti-self antibodies with high specificity from phage display libraries.
1993
Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process.
1994
Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
1993
Biologically active low density lipoprotein in human peripheral lymph.
1978 StandoutNobel
International Staging System for Multiple Myeloma
2005 Standout
Works of Erik Hippe being referenced
Renal function in newly diagnosed multiple myeloma — A demographic study of 1353 patients
1994
Autoantibodies to cytokines - friends or foes?
1990
Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial
1997
Measurement of health‐related quality of life in multiple myeloma
1996
Recombinant interferon‐alpha‐2b treatment of hairy‐cell leukaemia: Experience with a low‐dose schedule
1988
Health-Related Quality of Life in Multiple Myeloma Patients Receiving High-Dose Chemotherapy with Autologous Blood Stem-Cell Support
2001
Clinical Experience with Recombinant Factor VIla in Patients with Thrombocytopenia
1996
An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma
2007
Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia.
1995
Development of an EORTC questionnaire module to be used in health‐related quality‐of‐life assessment for patients with multiple myeloma
1999
Diurnal variations of serum erythropoietin in trained and untrained subjects
1993
Renal failure in multiple myeloma: reversibility and impact on the prognosis
2000
Recombinant human granulocyte‐macrophage colony‐stimulating factor plus recombinant human erythropoietin may improve anemia in selected patients with myelodysplastic syndromes
1993
Nature of vitamin B 12 binding. II. Steric orientation of vitamin B 12 on binding and number of combining sites of human intrinsic factor and the transcobalamins.
1971
VITAMIN B12 BINDING PROTEINS IN AMNIOTIC FLUID
1985
Adrenal cortical function as reflected by the plasma hydrocortisone and urinary 17-ketogenic steroids in relation to surgery in elderly patients.
1967
Nature of vitamin B12 binding
1971
Stokes radius of 57Co-labelled vitamin B12- transcobalamin I and II and 125I-labelled insulin estimated by sephadex G-2000 gel filtration in human plasma AT 37°
1969
IgM monoclonal gammopathy and neuropathy in two siblings.
1988
Reversible Dementia and Neuropathy Associated with Folate Deficiency 16 Years After Partial Gastrectomy
1981
Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.
1991
Nature of vitamin B 12 binding. 3. Thermodynamics of binding to human intrinsic factor and transcobalamins.
1971
Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group.
2000